Dow Up 0.26% Nasdaq Down 1.07%

NovaBay Pharmaceuticals, Inc. (NBY)

-NYSE MKT
0.80 Down 0.03(3.61%) 4:00PM EDT
Prev Close:0.83
Open:0.83
Bid:0.75 x 2000
Ask:0.86 x 1100
1y Target Est:1.45
Beta:0.89
Next Earnings Date:N/A
Day's Range:0.80 - 0.85
52wk Range:0.69 - 2.03
Volume:129,955
Avg Vol (3m):322,512
Market Cap:40.62M
P/E (ttm):N/A
EPS (ttm):-0.39
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NBY

Comparison

Symbol% ChgMkt Cap
NBYDown 3.61%40.62M
ABTUp 0.40%64.24B
PFEUp 1.66%189.72B
SNNUp 0.08%15.70B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):20.86
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.29
Quarterly EPS Est (Sep-14) :-0.09
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

NovaBay Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing product candidates for the therapeutic needs of anti-infective market. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback